174 related articles for article (PubMed ID: 16585385)
1. Altered expression of ezrin in esophageal squamous cell carcinoma.
Zeng H; Xu L; Xiao D; Zhang H; Wu X; Zheng R; Li Q; Niu Y; Shen Z; Li E
J Histochem Cytochem; 2006 Aug; 54(8):889-96. PubMed ID: 16585385
[TBL] [Abstract][Full Text] [Related]
2. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
[TBL] [Abstract][Full Text] [Related]
3. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
Faried A; Faried LS; Usman N; Kato H; Kuwano H
Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.
Xie JJ; Xu LY; Wu ZY; Zhao Q; Xu XE; Wu JY; Huang Q; Li EM
J Surg Oncol; 2011 Oct; 104(5):538-43. PubMed ID: 21416469
[TBL] [Abstract][Full Text] [Related]
7. The differential expression of SPARC in esophageal squamous cell carcinoma.
Che Y; Luo A; Wang H; Qi J; Guo J; Liu Z
Int J Mol Med; 2006 Jun; 17(6):1027-33. PubMed ID: 16685412
[TBL] [Abstract][Full Text] [Related]
8. Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma.
Madan R; Brandwein-Gensler M; Schlecht NF; Elias K; Gorbovitsky E; Belbin TJ; Mahmood R; Breining D; Qian H; Childs G; Locker J; Smith R; Haigentz M; Gunn-Moore F; Prystowsky MB
Head Neck; 2006 Nov; 28(11):1018-27. PubMed ID: 16783828
[TBL] [Abstract][Full Text] [Related]
9. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
[TBL] [Abstract][Full Text] [Related]
10. [Dysregulation of Annexin II expression in esophageal squamous cell cancer and adjacent tissues from a high-incidence area for esophageal cancer in Henan province].
Qi YJ; Wang LD; Jiao XY; Feng XS; Fan ZM; Gao SS; He X; Li JL; Chang FB
Ai Zheng; 2007 Jul; 26(7):730-6. PubMed ID: 17626749
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of MCM4 in esophageal cancer].
Huang XP; Zhang X; Su XD; Ma GW; Zhao JM; Rong TH
Ai Zheng; 2007 Jan; 26(1):96-9. PubMed ID: 17222376
[TBL] [Abstract][Full Text] [Related]
12. Initiation of malignancy by duodenal contents reflux and the role of ezrin in developing esophageal squamous cell carcinoma.
Ling ZQ; Mukaisho K; Yamamoto H; Chen KH; Asano S; Araki Y; Sugihara H; Mao WM; Hattori T
Cancer Sci; 2010 Mar; 101(3):624-30. PubMed ID: 20128822
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of SPRR3 expression in esophageal squamous cell carcinoma by qPCR and its potential use as a biomarker.
de A Simão T; Souza-Santos PT; de Oliveira DS; Bernardo V; Lima SC; Rapozo DC; Kruel CD; Faria PA; Ribeiro Pinto LF; Albano RM
Exp Mol Pathol; 2011 Oct; 91(2):584-9. PubMed ID: 21777580
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
[TBL] [Abstract][Full Text] [Related]
16. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.
Zhang H; Xu L; Xiao D; Xie J; Zeng H; Cai W; Niu Y; Yang Z; Shen Z; Li E
J Clin Pathol; 2006 Sep; 59(9):958-64. PubMed ID: 16524962
[TBL] [Abstract][Full Text] [Related]
17. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
[TBL] [Abstract][Full Text] [Related]
18. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.
Rahadiani N; Ikeda J; Makino T; Tian T; Qiu Y; Mamat S; Wang Y; Doki Y; Aozasa K; Morii E
Ann Surg Oncol; 2010 May; 17(5):1311-23. PubMed ID: 20066519
[TBL] [Abstract][Full Text] [Related]
19. Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.
Terashita Y; Ishiguro H; Haruki N; Sugiura H; Tanaka T; Kimura M; Shinoda N; Kuwabara Y; Fujii Y
Oncol Rep; 2004 Oct; 12(4):827-31. PubMed ID: 15375507
[TBL] [Abstract][Full Text] [Related]
20. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]